Part 3/6:
Disease Analysis and Hypothesis Generation: The first AI system analyzed existing data about IPF, including genetic, clinical, and biochemical information. This system aimed to understand the disease's underlying mechanisms and generate hypotheses about potential therapeutic targets—specific molecules or pathways that could be modulated to treat the disease.
Molecule Generation: The second AI system took these target insights and designed novel molecules tailored to interact with them. Using generative AI techniques, this system created chemical structures predicted to have the desired therapeutic properties.